Evidence map›Paper›PMID 38054103›Full record

ArticleDigital discovery2023

Automated MUltiscale simulation environment.

Albert Sabadell-Rendón, Kamila Kaźmierczak, Santiago Morandi, Florian Euzenat, Daniel Curulla-Ferré, Núria López

Abstract read
In one paragraph

Article in Digital discovery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Albert Sabadell-RendónInstitute of Chemical Research of Catalonia (ICIQ-CERCA), The Barcelona Institute of Science and Technology, (BIST) Av. Paisos Catalans 16 Tarragona 43007 Spain asabadell@iciq.es nlopez@iciq.es.
Kamila KaźmierczakTotalEnergies, TotalEnergies One Tech Belgium Zone industrielle C, 7181 Feluy Belgium.
Santiago MorandiInstitute of Chemical Research of Catalonia (ICIQ-CERCA), The Barcelona Institute of Science and Technology, (BIST) Av. Paisos Catalans 16 Tarragona 43007 Spain asabadell@iciq.es nlopez@iciq.es.ORCID https://orcid.org/0000-0003-0738-5612
Florian EuzenatTotalEnergies Research and Technology Gonfreville, Route Industrielle, Carrefour 4, Port 4864 76700 Rogerville France.
Daniel Curulla-FerréTotalEnergies, TotalEnergies One Tech Belgium Zone industrielle C, 7181 Feluy Belgium.
Núria LópezInstitute of Chemical Research of Catalonia (ICIQ-CERCA), The Barcelona Institute of Science and Technology, (BIST) Av. Paisos Catalans 16 Tarragona 43007 Spain asabadell@iciq.es nlopez@iciq.es.ORCID https://orcid.org/0000-0001-9150-5941

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiscale techniques integrating detailed atomistic information on materials and reactions to predict the performance of heterogeneous catalytic full-scale reactors have been suggested but lack seamless implementation. The largest challenges in the multiscale modeling of reactors can be grouped into two main categories: catalytic complexity and the difference between time and length scales of chemical and transport phenomena. Here we introduce the Automated MUltiscale Simulation Environment AMUSE, a workflow that starts from Density Functional Theory (DFT) data, automates the analysis of the reaction networks through graph theory, prepares it for microkinetic modeling, and subsequently integrates the results into a standard open-source Computational Fluid Dynamics (CFD) code. We demonstrate the capabilities of AMUSE by applying it to the unimolecular iso-propanol dehydrogenation reaction and then, increasing the complexity, to the pre-commercial Pd/In

Identifiers

PMID38054103
PMCPMC10694852

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.